Nomura Holdings Inc. decreased its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 57.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 35,802 shares of the semiconductor company’s stock after selling 49,221 shares during the quarter. Nomura Holdings Inc.’s holdings in Synopsys were worth $4,705,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in SNPS. Egerton Capital UK LLP raised its holdings in Synopsys by 142.3% in the 1st quarter. Egerton Capital UK LLP now owns 2,199,485 shares of the semiconductor company’s stock worth $253,271,000 after purchasing an additional 1,291,643 shares during the period. JPMorgan Chase & Co. raised its holdings in Synopsys by 18.1% in the 2nd quarter. JPMorgan Chase & Co. now owns 6,228,559 shares of the semiconductor company’s stock worth $782,432,000 after purchasing an additional 955,527 shares during the period. Invesco Ltd. raised its holdings in shares of Synopsys by 33.9% during the second quarter. Invesco Ltd. now owns 3,505,038 shares of the semiconductor company’s stock valued at $451,061,000 after acquiring an additional 888,033 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Synopsys by 4.5% during the second quarter. BlackRock Inc. now owns 12,891,437 shares of the semiconductor company’s stock valued at $1,658,997,000 after acquiring an additional 554,602 shares during the last quarter. Finally, Marshall Wace North America L.P. raised its holdings in shares of Synopsys by 2,163.3% during the first quarter. Marshall Wace North America L.P. now owns 546,217 shares of the semiconductor company’s stock valued at $62,897,000 after acquiring an additional 522,083 shares during the last quarter. 89.28% of the stock is owned by institutional investors.
Shares of Synopsys stock opened at $136.21 on Friday. Synopsys, Inc. has a fifty-two week low of $79.14 and a fifty-two week high of $146.66. The stock has a 50 day moving average of $135.93 and a 200 day moving average of $125.85. The firm has a market capitalization of $20.95 billion, a price-to-earnings ratio of 34.08, a PEG ratio of 3.69 and a beta of 1.23. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.90 and a current ratio of 0.99.
Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, August 21st. The semiconductor company reported $0.65 EPS for the quarter, topping the consensus estimate of $0.62 by $0.03. The business had revenue of $853.00 million during the quarter, compared to analyst estimates of $831.03 million. Synopsys had a return on equity of 16.56% and a net margin of 18.94%. The company’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period last year, the business posted $0.95 earnings per share. Analysts forecast that Synopsys, Inc. will post 3.15 EPS for the current year.
In other news, General Counsel John F. Runkel, Jr. sold 10,000 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $137.47, for a total value of $1,374,700.00. Following the sale, the general counsel now directly owns 16,848 shares in the company, valued at $2,316,094.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Chi-Foon Chan sold 4,578 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $137.14, for a total value of $627,826.92. Following the completion of the sale, the chief executive officer now owns 199,539 shares in the company, valued at $27,364,778.46. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,589 shares of company stock worth $3,158,514. Insiders own 1.84% of the company’s stock.
A number of equities analysts have commented on the company. Zacks Investment Research raised Synopsys from a “sell” rating to a “hold” rating and set a $142.00 target price for the company in a report on Monday, August 26th. Credit Suisse Group reissued a “positive” rating and set a $150.00 target price (up previously from $125.00) on shares of Synopsys in a report on Thursday, August 22nd. KeyCorp increased their target price on Synopsys from $152.00 to $153.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. JPMorgan Chase & Co. increased their price target on Synopsys from $138.00 to $157.00 and gave the company a “neutral” rating in a report on Wednesday, September 11th. Finally, Wells Fargo & Co reaffirmed an “outperform” rating and issued a $160.00 price target (up previously from $150.00) on shares of Synopsys in a report on Thursday, August 22nd. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Synopsys has a consensus rating of “Buy” and a consensus target price of $145.64.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Article: Trading Penny Stocks
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.